FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.ebm
Resource TypeEvidence
IdEvidence-379738.json
FHIR VersionR6

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: Evidence 379738

version: 5; Last updated: 2025-07-01 16:36:53+0000; Language: en

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/Evidence/379738

identifier: FEvIR Object Identifier/379738

name: Evidence_for_Results_for_Hypertension_Control_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan

title: Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan

citeAs:

Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 379738. Revised 2025-07-01. Available at: https://fevir.net/resources/Evidence/379738. Computable resource at: https://fevir.net/resources/Evidence/379738#json.

status: Active

author: Joanne Dehnbostel:

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

RelatesTos

-TypeTarget[x]
*Part OfOutcome Measure Report for QUARTET USA Trial

description:

This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.

variableDefinition

variableRole: Population

observed: GroupAssignment: Quadpill vs. Candesartan

variableDefinition

variableRole: Outcome

observed: Hypertension Control at 12 weeks

statistic

statisticType: odds ratio

quantity: 2.85

numberAffected: 32

SampleSizes

-ExtensionNumberOfParticipantsKnownDataCount
*6253

attributeEstimate

type: confidence interval

level: 0.95

range: 0.94-8.59

attributeEstimate

type: p-value

quantity: 0.063


Source1

{
  "resourceType": "Evidence",
  "id": "379738",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2025-07-01T16:36:53.204Z"
  },
  "language": "en",
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
            "code": "active",
            "display": "Active"
          }
        ]
      }
    }
  ],
  "url": "https://fevir.net/resources/Evidence/379738",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "379738",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "name": "Evidence_for_Results_for_Hypertension_Control_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan",
  "title": "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan",
  "citeAs": "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 379738. Revised 2025-07-01. Available at: https://fevir.net/resources/Evidence/379738. Computable resource at: https://fevir.net/resources/Evidence/379738#json.",
  "status": "active",
  "author": [
    {
      "name": "Joanne Dehnbostel"
    }
  ],
  "publisher": "Computable Publishing LLC",
  "contact": [
    {
      "telecom": [
        {
          "system": "email",
          "value": "support@computablepublishing.com"
        }
      ]
    }
  ],
  "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "relatesTo": [
    {
      "type": "part-of",
      "targetReference": {
        "reference": "Composition/375280",
        "type": "Composition",
        "display": "Outcome Measure Report for QUARTET USA Trial"
      }
    }
  ],
  "description": "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
  "variableDefinition": [
    {
      "variableRole": "population",
      "observed": {
        "reference": "EvidenceVariable/375183",
        "type": "EvidenceVariable",
        "display": "GroupAssignment: Quadpill vs. Candesartan"
      }
    },
    {
      "variableRole": "outcome",
      "observed": {
        "reference": "EvidenceVariable/375202",
        "type": "EvidenceVariable",
        "display": "Hypertension Control at 12 weeks"
      }
    }
  ],
  "statistic": [
    {
      "statisticType": {
        "coding": [
          {
            "system": "https://fevir.net/sevco",
            "code": "STATO:0000182",
            "display": "odds ratio"
          }
        ]
      },
      "quantity": {
        "value": 2.85
      },
      "numberAffected": 32,
      "sampleSize": {
        "extension": [
          {
            "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/number-analyzed",
            "valueUnsignedInt": 60
          }
        ],
        "numberOfParticipants": 62,
        "knownDataCount": 53
      },
      "attributeEstimate": [
        {
          "type": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000196",
                "display": "confidence interval"
              }
            ]
          },
          "level": 0.95,
          "range": {
            "low": {
              "value": 0.94
            },
            "high": {
              "value": 8.59
            }
          }
        },
        {
          "type": {
            "coding": [
              {
                "system": "https://fevir.net/sevco",
                "code": "STATO:0000700",
                "display": "p-value"
              }
            ]
          },
          "quantity": {
            "value": 0.063
          }
        }
      ]
    }
  ]
}